A carregar...
Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-Cell Lymphoma
INTRODUCTION: Diffuse large B-cell lymphoma (DLBCL) is genetically and clinically heterogeneous. Despite advances in genomic subtyping, standard frontline chemoimmunotherapy has remained unchanged for years. As high-throughput analysis becomes more accessible, characterizing drug-gene interactions i...
Na minha lista:
| Publicado no: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7136133/ https://ncbi.nlm.nih.gov/pubmed/32063526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.12.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|